This topic contains a solution. Click here to go to the answer

Author Question: By what age do most patients with Duchenne muscular dystrophy die? a. 10 years b. 20 years c. ... (Read 58 times)

Collmarie

  • Hero Member
  • *****
  • Posts: 569
By what age do most patients with Duchenne muscular dystrophy die?
 
  a. 10 years
  b. 20 years
  c. 35 years
  d. 50 years

Question 2

What respiratory dysfunction is commonly seen in myotonic dystrophy?
 
  a. Sleep-related disorders
  b. Pulmonary fibrosis
  c. Obstructive pulmonary disease
  d. Pulmonary edema



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cloud

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

ANS: B
Death generally occurs by 20 years of age, as a result of complications of declining respiratory muscle strength and subsequent infection.

Answer to Question 2

ANS: A
Sleep-related disorders are particularly common, even at an early age.




Collmarie

  • Member
  • Posts: 569
Reply 2 on: Jul 16, 2018
YES! Correct, THANKS for helping me on my review


bulacsom

  • Member
  • Posts: 329
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library